PDS Biotechnology Corporation - Common Stock (PDSB)

Sept. 15, 2026 - Small-cap stocks PDS Biotechnology Corporation (NASDAQ: PDSB), IGC Pharma, Inc. (NYSE: IGC), Peraso Inc. (NASDAQ: PRSO) and ReTo Eco-Solutions, Inc. (NASDAQ: RETO) are in focus following recent pullbacks, with each company carrying potential catalysts across cancer immunotherapy, Alzheimer's biotechnology and AI, military autonomy, defense technology and intelligent industrial equipment .

Sept. 15, 2026 - Investors looking across emerging-growth and small-cap stocks are watching Veea Inc. (NASDAQ: VEEA), Sphere 3D Corp. d/b/a DarkHorse Technologies (NASDAQ: ANY), DataMEDS AI, Inc. (NASDAQ: MEDS), MySize, Inc. (NASDAQ: MYSZ) and PDS Biotechnology Corporation (NASDAQ: PDSB) as developments spanning AI healthcare, AI infrastructure, GPU computing, defense technology and cancer immunotherapy create potential catalysts across the group.

Sept. 8, 2026 Mobix Labs Inc. (NASDAQ: MOBX) and Peraso Inc. (NASDAQ: PRSO) are gaining attention across the expanding defense technology market, with Mobix Labs securing its initial production order supporting the F-16 Fighting Falcon and Peraso positioning its 60GHz mmWave technology across military robotics, UAVs and autonomous systems .

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

NEW YORK, NY / ACCESSWIRE / December 5, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with PDS Biotechnology Corporation.

Palm Beach, FL – October 6, 2022 – FinancialNewsMedia.com News Commentary – The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing CAGR. Cervical Cancer is a cancer arising from the cervix which is due to the abnormal growth of cells that have the ability […]